[HTML][HTML] The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K Kato, H Iwama, T Yamashita… - Oncology …, 2016 - spandidos-publications.com
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K Kato, H Iwama, T Yamashita, K Kobayashi… - Oncology …, 2015 - europepmc.org
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K KATO, H IWAMA, T YAMASHITA, K KOBAYASHI… - ingentaconnect.com
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
[引用][C] The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K KATO, H IWAMA, T YAMASHITA, K KOBAYASHI… - Oncology …, 2015 - cir.nii.ac.jp
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo:
Study of the microRNAs associated with the antitumor effect of metformin | CiNii Research CiNii …
Study of the microRNAs associated with the antitumor effect of metformin | CiNii Research CiNii …
[PDF][PDF] The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K KATO, H IWAMA, T YAMASHITA, K KOBAYASHI… - scholar.archive.org
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K Kato, H Iwama, T Yamashita… - Oncology …, 2016 - pubmed.ncbi.nlm.nih.gov
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
[HTML][HTML] The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K Kato, H Iwama, T Yamashita… - Oncology …, 2016 - spandidos-publications.com
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K KATO, H IWAMA, T YAMASHITA… - Oncology …, 2016 - search.proquest.com
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
[PDF][PDF] The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K KATO, H IWAMA, T YAMASHITA, K KOBAYASHI… - researchgate.net
Recent studies suggest that metformin, which is a commonly used oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of …
K Kato, H Iwama, T Yamashita, K Kobayashi… - Oncology …, 2016 - go.gale.com
Recent studies suggest that metformin, which is a commonlyused oral anti-hyperglycemic
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …
agent of the biguanide family, may reduce cancer risk and improve prognosis, yet the …